Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01032902 · ClinicalTrials.gov registry record

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

A clinical trial of HIV Infections, sponsored by Chembio Diagnostic Systems.

Completed
Registry status
2,808
Enrollment target
5
Study locations

NCT01032902: Completed study of HIV Infections, sponsored by Chembio Diagnostic Systems.

NCT01032902 is a study of HIV Infections that has completed, run by Chembio Diagnostic Systems. The registered enrollment target is 2,808 participants, above the 441-participant average among 542 other HIV Infections trials with a reported enrollment target (537% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01032902, a study of HIV Infections, has completed, sponsored by Chembio Diagnostic Systems.

COMPLETED
Registry status
2,808 participants
Enrollment target
5
Study locations

Study Summary

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of antibodies against HIV-1/2 in oral fluid, whole blood (capillary and venous), serum or plasma. This study will assess the DPP® HIV 1/2 Screen assay's ability to detect HIV-1.

Conditions Studied

HIV Infections

Interventions

  • DEVICE In Vitro Diagnostic Device

Study Locations (5)

California

  • Univeristy of California, San Diego - La Jolla

Florida

  • Therafirst - Fort Lauderdale

Maryland

  • University of Maryland - Baltimore

Pennsylvania

  • St. Christopher's Hospital for Children/ Drexel University College of Medicine - Philadelphia

Texas

  • University of Texas HSC - Houston

Trial Details

FieldValue
Enrollment Target 2,808 participants
Start Date 2010-01
Est. Completion 2012-04

Sponsor

Chembio Diagnostic Systems

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01032902

The ClinicalTrials.gov registry entry for NCT01032902 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,808 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 441-participant average among 542 other HIV Infections trials with a reported enrollment target (537% higher). The listed sponsor is Chembio Diagnostic Systems, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which In Vitro Diagnostic Device is the first listed.

NCT01032902 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Maryland.

Frequently Asked Questions

What is clinical trial NCT01032902 about?

NCT01032902 is a clinical study titled "Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test". This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of antibodies against HIV-1/2 in oral fluid, whole blood (capillary and venous), serum or plasma. This study will ass...

What is the current status of trial NCT01032902?

This trial is currently completed. The enrollment target is 2,808 participants. The study started on 2010-01. Estimated completion is 2012-04.

What conditions does trial NCT01032902 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT01032902?

The interventions under investigation include: In Vitro Diagnostic Device (DEVICE).

Who is sponsoring clinical trial NCT01032902?

This trial is sponsored by Chembio Diagnostic Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01032902 being conducted?

This trial has 5 study locations across California, Florida, Maryland, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.